Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
About
Pricing
Company Reports
BeOne Medicines
BeOne Medicines
(ONC)
Download report
Favorite
Financial
Marketed Drugs
Clinical Trials
Financial
Stock price
*Currency in USD
Company Revenue
Quarterly
Quarterly
Annual
Annual
Projections
*Quarterly sales USD (in millions)
Mock data
Subscribe for the real data
Revenue by Drug
Marketed Drugs
Therapeutic Areas:
All
Classification:
All
Include Generics:
Trade Name
Drug Name
Approved
Patent Expires
Indication
Brukinsa
Zanubrutinib
2019-11-14
2034-2043
Mantle-cell lymphoma
,
Waldenstrom macroglobulinemia
Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Drug Name
Phase 1
Phase 2
Phase 3
Phase 4
Indication
Zanubrutinib
healthy volunteers/patients
,
liver failure
,
hepatic insufficiency
,
lymphoma
,
neoplasms
,
b-cell lymphoma
,
b-cell chronic lymphocytic leukemia
,
b-cell lymphoma marginal zone
,
mantle-cell lymphoma
,
large b-cell lymphoma diffuse
,
leukemia
,
lymphoid leukemia
,
lupus nephritis
,
nephritis
,
covid-19
,
follicular lymphoma
,
prolymphocytic leukemia t-cell
,
paraproteinemias
,
polyneuropathies
,
monoclonal gammopathy of undetermined significance
,
waldenstrom macroglobulinemia
Docusate
liver diseases
,
liver transplantation
,
cardiac surgical procedures
Histidine
uterine cervical neoplasms
,
neoplasms
,
triple negative breast neoplasms
,
non-small-cell lung carcinoma
,
lung neoplasms
Benzimidazole
healthy volunteers/patients
,
drug interactions
,
atopic dermatitis
,
eczema
,
dermatitis
,
multiple myeloma
,
plasma cell neoplasms
,
papillary thyroid cancer
,
autoimmune diseases
,
amyloidosis
,
multiple sclerosis
,
relapsing-remitting multiple sclerosis
,
sclerosis
Sitravatinib
neoplasms
,
biliary tract neoplasms
,
uterine cervical neoplasms
,
carcinoma
,
hepatocellular carcinoma
,
liver neoplasms
Ociperlimab
carcinoma
,
squamous cell carcinoma
,
esophageal squamous cell carcinoma
,
uterine cervical neoplasms
,
small cell lung carcinoma
,
liver neoplasms
,
neoplasm metastasis
,
lymphoma
,
large b-cell lymphoma diffuse
,
non-small-cell lung carcinoma
,
lung neoplasms
,
neoplasms
Cilmostim
neoplasm metastasis
,
meningeal neoplasms
,
meningeal carcinomatosis
,
hodgkin disease
Gilvetmab
neoplasms
,
squamous cell carcinoma of head and neck
,
carcinoma
,
colorectal neoplasms
,
glioblastoma
,
esophageal squamous cell carcinoma
,
astrocytoma
,
hepatocellular carcinoma
,
liver neoplasms
,
prostatic neoplasms
,
castration-resistant prostatic neoplasms
,
sarcoma
,
small cell lung carcinoma
,
malignant mesothelioma
,
neuroendocrine tumors
,
neuroendocrine carcinoma
,
squamous cell neoplasms
,
mesothelioma
,
colonic neoplasms
,
neoplasm metastasis
,
spinocerebellar degenerations
Surufatinib
cholangiocarcinoma
Aglatimagene besadenovec
lower urinary tract symptoms
,
prostatic neoplasms
,
prostatic hyperplasia
,
melanoma
,
neuroendocrine tumors
,
pituitary neoplasms
,
pituitary acth hypersecretion
,
pituitary diseases
,
acth-secreting pituitary adenoma
,
dumping syndrome
,
acromegaly
,
hyperplasia
Vicriviroc
lung neoplasms
,
small cell lung carcinoma
,
neuroendocrine tumors
,
neuroendocrine carcinoma
Tenofovir
hepatitis b virus
,
chronic hepatitis b
,
hepatitis
,
hepatitis b
,
hepatitis a
Doconexent
multiple myeloma
,
low back pain
,
back pain
,
breast neoplasms
,
mucinous adenocarcinoma
,
ductal carcinoma breast
,
inflammatory breast neoplasms
,
treatment-resistant depressive disorder
Regramostim
ovarian neoplasms
,
fallopian tube neoplasms
,
peritoneal neoplasms
Lornoxicam
breast neoplasms
1
2
3
4
>
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) |
Terms of Use